Drug intelligence / Profile preview

yigongsan

Development stage
Unknown
Lead developer
China Shineway Pharmaceutical Group
Administration
Oral
01

Overview

Yigongsan is a Traditional Chinese Medicine (TCM) herbal formula composed of five primary ingredients: Panax ginseng (or Codonopsis pilosula), Atractylodes macrocephala, Poria cocos, Glycyrrhiza uralensis, and Citrus reticulata. It is a classic modification of the Sijunzi Tang (Four Gentlemen Decoction) with the addition of dried tangerine peel (Chenpi). Developed as a modern pharmaceutical granule by Shineway Pharmaceutical Group, it is currently being investigated in Phase II clinical trials for the treatment of anemia of chronic disease (specifically spleen qi deficiency syndrome) in patients with stage 3-4 chronic kidney disease. The formula is traditionally used to tonify spleen qi, regulate qi flow, and harmonize the stomach, which in a modern clinical context is intended to improve nutritional status and support hematopoiesis.

Other names
Yigongsan GranulesYi Gong San异功散
02

Targets

MMP2 (Matrix metalloproteinase-2)MMP9 (Matrix metalloproteinase-9)EGFR T790M (Epidermal growth factor receptor T790M mutant)TGFB1 (Transforming growth factor Beta-1 proprotein)IL-6 (Interleukin 6)

Beyond the preview

Go deeper on yigongsan.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Full profile access

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Full profile access

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Full profile access

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Full profile access

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Full profile access

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on yigongsan.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call